E-LIB Suche - Ergebnisse für: Brakedal, Brage

1

Nicotinamide riboside supplementation is not associated wit..:

Gaare, Johannes J. ; Dölle, Christian ; Brakedal, Brage...
iScience. 26 (2023) 3 - p. 106278 , 2023

2

Nicotinamide riboside supplementation is not associated wit..:

Johannes J. Gaare ; Christian Dölle ; Brage Brakedal...
http://www.sciencedirect.com/science/article/pii/S2589004223003553. , 2023

Link: https://doi.org/10.1016/..

3

Nicotinamide riboside supplementation is not associated wit..:

Gaare, Johannes Jernqvist ; Dölle, Christian ; Brakedal, Brage...
urn:issn:2589-0042. , 2023

Link: https://hdl.handle.net/1..

4

Nicotinamide riboside supplementation is not associated wit..:

Gaare, Johannes J ; Dölle, Christian ; Brakedal, Brage...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014306/. , 2023

Link: http://www.ncbi.nlm.nih...

5

The NADPARK study: A randomized phase I trial of nicotinami..:

Brakedal, Brage ; Dölle, Christian ; Riemer, Frank...
Cell Metabolism. 34 (2022) 3 - p. 396-407.e6 , 2022

Link: https://doi.org/10.1016/..

6

A nationwide study of the incidence, prevalence and mortali..:

Brakedal, Brage ; Toker, Lilah ; Haugarvoll, Kristoffer.
npj Parkinson's Disease. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

7

A nationwide study of the incidence, prevalence and mortali..:

Brakedal, Brage ; Toker, Lilah ; Haugarvoll, Kristoffer.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891365/. , 2022

Link: http://www.ncbi.nlm.nih...

8

The NADPARK study: A randomized phase I trial of nicotinami..:

Brakedal, Brage ; Dölle, Christian ; Riemer, Frank...
urn:issn:1550-4131. , 2022

Link: https://hdl.handle.net/1..

9

A nationwide study of the incidence, prevalence and mortali..:

Brage Brakedal ; Lilah Toker ; Kristoffer Haugarvoll.
https://doi.org/10.1038/s41531-022-00280-4. , 2022

Link: https://doi.org/10.1038/..

10

A nationwide study of the incidence, prevalence and mortali..:

Brakedal, Brage ; Toker, Lilah ; Haugarvoll, Kristoffer.
urn:issn:2373-8057. , 2022

Link: https://hdl.handle.net/1..

11

NSAID use is not associated with Parkinson's disease incide..:

Brakedal, Brage ; Tzoulis, Charalampos ; Tysnes, Ole-Bjørn..
PLOS ONE. 16 (2021) 9 - p. e0256602 , 2021

Link: https://doi.org/10.1371/..

12

Results from time-dependent Cox regression analysis and bin..:

Brage Brakedal (11402109) ; Charalampos Tzoulis (421795) ; Ole-Bjørn Tysnes (4714437).
https://figshare.com/articles/dataset/Results_from_time-dependent_Cox_regression_analysis_and_binary_logistic_regression_analysis_/16580112. , 2021

Link: https://doi.org/10.1371/..

13

Demographics and descriptive statistics for Norwegian Presc..:

Brage Brakedal (11402109) ; Charalampos Tzoulis (421795) ; Ole-Bjørn Tysnes (4714437).
https://figshare.com/articles/journal_contribution/Demographics_and_descriptive_statistics_for_Norwegian_Prescription_registry_groups_used_in_binary_logistic_5-year_lag_regression_analysis_with_90DDD_sup_a_sup_threshold_/16580097. , 2021

Link: https://doi.org/10.1371/..

14

Age-adjusted incidence rates for Norwegian Prescription Dat..:

Brage Brakedal (11402109) ; Charalampos Tzoulis (421795) ; Ole-Bjørn Tysnes (4714437).
https://figshare.com/articles/dataset/Age-adjusted_incidence_rates_for_Norwegian_Prescription_Database_/16580109. , 2021

Link: https://doi.org/10.1371/..

15

Demographics and descriptive statistics for Norwegian Presc..:

Brage Brakedal (11402109) ; Charalampos Tzoulis (421795) ; Ole-Bjørn Tysnes (4714437).
https://figshare.com/articles/dataset/Demographics_and_descriptive_statistics_for_Norwegian_Prescription_Database_groups_used_in_binary_logistic_5_year-lag_analysis_with_90_DDD_sup_a_sup_threshold_/16580106. , 2021

Link: https://doi.org/10.1371/..